G. Tarantino

发表

Mammalian Target of Rapamycin in Inflammatory Skin Conditions

M. Megna, N. Balato, A. Balato, 2014 .

New Avenues for Treatment and Prevention of Drug-Induced Steatosis and Steatohepatitis: Much More Than Antioxidants

M. Cataldi, G. Tarantino, V. Citro, 2021, Advances in Therapy.

Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease.

G. Tarantino, A. Di Minno, P. Ambrosino, 2012, World journal of gastroenterology.

Oleuropein Induces AMPK-Dependent Autophagy in NAFLD Mice, Regardless of the Gender

G. Tarantino, C. Balsano, A. Galli, 2018, International journal of molecular sciences.

Is visceral fat reduction necessary to favour metabolic changes in the liver?

G. Tarantino, C. Finelli, 2012, Journal of gastrointestinal and liver diseases : JGLD.

Copper-catalyzed dicarbonyl stress in NAFLD mice: protective effects of Oleuropein treatment on liver damage

G. Tarantino, A. Alisi, C. Balsano, 2022, Nutrition & Metabolism.

Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively?

G. Tarantino, D. Capone, F. Pasanisi, 2009, Journal of Inflammation.

Low daily dosage of interferon for 1 year after HCV‐related end‐therapy response. A randomized‐controlled study

G. Tarantino, O. Perrella, A. Perrella, 2003, Liver international : official journal of the International Association for the Study of the Liver.

Clinical factors affecting prostate-specific antigen levels in prostate cancer patients undergoing radical prostatectomy: a retrospective study

M. Creta, G. Tarantino, C. Imbimbo, 2021, Future science OA.

Serum levels of Lp(a) are related to waist circumference in NAFLD patients with low prevalence of co-morbidities

G. Tarantino, M. Gentile, V. Citro, 2016, Scandinavian journal of clinical and laboratory investigation.

Absence of Pharmacokinetic Interference of Moxifloxacin on Cyclosporine and Tacrolimus in Kidney Transplant Recipients

M. Sabbatini, S. Federico, G. Tarantino, 2010, Journal of clinical pharmacology.

A Lupus Hepatitis Case and its Association with Igm Antibodies against Cytomegalovirus, Herpes Simplex and Herpes Zoster Viruses

G. Tarantino, A. Riccio, R. Morante, 2009 .

Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation.

M. Megna, M. Napolitano, N. Balato, 2015, World journal of gastroenterology.

Relationships of PAI-1 levels to central obesity and liver steatosis in a sample of adult male population in southern Italy

G. Tarantino, E. Farinaro, F. Galletti, 2009, Internal and emergency medicine.

Carotid Intima-Media Thickness Is Predicted by Combined Eotaxin Levels and Severity of Hepatic Steatosis at Ultrasonography in Obese Patients with Nonalcoholic Fatty Liver Disease

S. Costantini, G. Tarantino, G. Castello, 2014, PloS one.

Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status.

F. Orio, A. Colao, G. Tarantino, 2015, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Recreational drugs: a new health hazard for patients with concomitant chronic liver diseases.

G. Tarantino, V. Citro, C. Finelli, 2014, Journal of gastrointestinal and liver diseases : JGLD.

Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?

G. Tarantino, M. Padula, G. Martelli, 2014, World journal of gastroenterology.

Hype or Reality: Should Patients with Metabolic Syndrome-related NAFLD be on the Hunter-Gatherer (Paleo) Diet to Decrease Morbidity?

G. Tarantino, V. Citro, C. Finelli, 2015, Journal of gastrointestinal and liver diseases : JGLD.

A Clinical–Morphological Study on Cholestatic Presentation of Nonalcoholic Fatty Liver Disease

G. Tarantino, O. Perrella, P. Micheli, 2005, Digestive Diseases and Sciences.

Nutrition, inflammation and liver-spleen axis

F. Orio, G. Muscogiuri, G. Tenore, 2018, Critical reviews in food science and nutrition.

Should visceral fat be reduced to increase longevity?

G. Tarantino, C. Finelli, S. Gioia, 2013, Ageing Research Reviews.

Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease.

G. Tarantino, P. Babica, J. Bienertová-Vašků, 2021, Metabolism: clinical and experimental.

Are hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-transferase?

A. Colao, G. Tarantino, D. Capone, 2012, Journal of Translational Medicine.

Clinical presentation and prevalence of spontaneous bacterial peritonitis in patients with cryptogenic cirrhosis and features of metabolic syndrome.

G. Tarantino, O. Perrella, A. Perrella, 2004, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Non-Alcoholic Fatty Liver Disease in Young Adult Severely Obese Non-Diabetic Patients in South Italy

G. Tarantino, F. Contaldo, F. Pasanisi, 2005, Annals of Nutrition and Metabolism.

Non‐alcoholic fatty liver disease: Further expression of the metabolic syndrome

G. Tarantino, P. Conca, G. Saldalamacchia, 2007, Journal of gastroenterology and hepatology.

Cytokine network during NASH and possible treatment selection

A. Moser, G. Tarantino, P. Watkins, 2003 .

Could High Levels of Tissue Polypeptide Specific Antigen, a Marker of Apoptosis Detected in Nonalcoholic Steatohepatitis, Improve after Weight Loss?

G. Tarantino, M. D. Di Minno, P. Conca, 2009, Disease markers.

Liver-spleen axis, insulin-like growth factor-(IGF)-I axis and fat mass in overweight/obese females

F. Orio, A. Colao, G. Tarantino, 2011, Journal of Translational Medicine.

Is there any consensus as to what diet or lifestyle approach is the right one for NAFLD patients?

G. Tarantino, C. Finelli, 2012, Journal of gastrointestinal and liver diseases : JGLD.

Reliability of total overnight salivary caffeine assessment (TOSCA) for liver function evaluation in compensated cirrhotic patients

G. Tarantino, D. Capone, G. Polichetti, 2006, European Journal of Clinical Pharmacology.

Could quantitative liver function tests gain wide acceptance among hepatologists?

G. Tarantino, 2009, World journal of gastroenterology.

Serum 25-Hydroxyvitamin D Levels, phosphoprotein enriched in diabetes gene product (PED/PEA-15) and leptin-to-adiponectin ratio in women with PCOS

F. Orio, P. Formisano, F. Beguinot, 2011, Nutrition & metabolism.

Interferon-alpha2 but not Interferon-gamma serum levels are associated with intramuscular fat in obese patients with nonalcoholic fatty liver disease

S. Costantini, G. Tarantino, D. Capone, 2018, bioRxiv.

Hepatic steatosis, carotid plaques and achieving MDA in psoriatic arthritis patients starting TNF-α blockers treatment: a prospective study

G. Tarantino, M. D. Di Minno, R. Scarpa, 2012, Arthritis Research & Therapy.

Hepatic Steatosis and Disease Activity in Subjects with Psoriatic Arthritis Receiving Tumor Necrosis Factor-α Blockers

G. Tarantino, G. Di Minno, M. D. Di Minno, 2012, The Journal of Rheumatology.

PaO2/FiO2 ratio forecasts COVID-19 patients’ outcome regardless of age: a cross-sectional, monocentric study

G. Tarantino, C. Mastroianni, C. Balsano, 2021, Internal and Emergency Medicine.

Insulin-like Growth Factor-1, Psoriasis, and Inflammation: A Ménage à Trois?

N. Balato, A. Colao, G. Tarantino, 2011 .

Phenotyping of CYP 4501A2 Activity by Total Overnight Salivary Caffeine Assessment (TOSCA) in Patients on Warfarin Treatment: A Cross-Sectional Study

G. Tarantino, D. Capone, A. Tufano, 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Liver-spleen axis in nonalcoholic fatty liver disease

G. Tarantino, C. Balsano, V. Citro, 2021, Expert review of gastroenterology & hepatology.

What does irritable bowel syndrome share with non-alcoholic fatty liver disease?

G. Tarantino, M. D. Di Minno, A. Scalera, 2013, World journal of gastroenterology.

Polycystic Ovary Syndrome and Hepatic Steatosis: Could Low-Grade Chronic Inflammation Be Mediated by the Spleen?

F. Orio, A. Colao, G. Tarantino, 2013 .

Liver-spleen axis: intersection between immunity, infections and metabolism.

G. Tarantino, C. Finelli, A. Scalera, 2013, World journal of gastroenterology.

Bisphenol A in polycystic ovary syndrome and its association with liver–spleen axis

F. Orio, P. Formisano, A. Colao, 2013, Clinical endocrinology.

It Is High Time Physicians Thought of Natural Products for Alleviating NAFLD. Is There Sufficient Evidence to Use Them?

G. Tarantino, C. Balsano, S. Santini, 2021, International Journal of Molecular Sciences.

What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?

G. Tarantino, C. Finelli, 2013, World journal of gastroenterology.

Findings from Studies Are Congruent with Obesity Having a Viral Origin, but What about Obesity-Related NAFLD?

M. Cataldi, G. Tarantino, V. Citro, 2021, Viruses.

JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease.

G. Tarantino, A. Caputi, 2011, World journal of gastroenterology.

Lipids, Low-Grade Chronic Inflammation and NAFLD: A Ménage À Trois?

G. Tarantino, C. Finelli, 2016 .

WITHDRAWN: Could some epigenetic modifications hold the key to opposing the metabolic syndrome?

G. Tarantino, M. D. Di Minno, C. Finelli, 2015, Oncotarget.

Lipids, Low-Grade Chronic Inflammation and NAFLD

G. Tarantino, C. Finelli, 2016 .

Lipids Nutrition and Epigenetic Modification in Obesity-Related Co-Morbitities**All authors equally contributed to draft the manuscript. All authors gave final approval of the version to be published. Disclosure statement: The authors declare that there are no conflicts of interest

G. Tarantino, C. Finelli, 2016 .

Interferon-alpha 2 but not Interferon-gamma serum levels are associated with intramuscular fat in obese patients with nonalcoholic fatty liver disease

S. Costantini, G. Tarantino, D. Capone, 2018, Journal of Translational Medicine.

High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism.

G. Tarantino, G. Di Minno, A. Tufano, 2010, World journal of gastroenterology.

Is there a direct role of hepatitis C virus in portosystemic encephalopathy?

G. Tarantino, 2008, Journal of Gastroenterology.

Prediction of carotid intima–media thickness in obese patients with low prevalence of comorbidities by serum copper bioavailability

G. Tarantino, C. Balsano, C. Porcu, 2018, Journal of gastroenterology and hepatology.

Is NAFLD an incidentaloma?

G. Tarantino, 2006, Gastroenterology.

The role of alcoholic and metabolic co-factors in chronic hepatitis C.

G. Tarantino, P. Conca, P. Sorrentino, 2004, Gastroenterology.

Incidence of hypertension in individuals with different blood pressure salt-sensitivity: results of a 15-year follow-up study

F. Cappuccio, A. Siani, G. Tarantino, 2007, Journal of hypertension.

Successful and Safe Long-Term Standard Antiviral Therapy in a Patient with “Explosive” Immune Response in Course of HCV-Related Liver Cirrhosis

G. Tarantino, A. Coppola, A. De Renzo, 2015, International journal of molecular sciences.

HCV infection and chronic arthritis: Does viral replication matter?

G. Tarantino, A. Riccio, R. Scarpa, 2006, Hepatology research : the official journal of the Japan Society of Hepatology.

IS THE ROLE OF APOPTOSIS DEFINITELY

G. Tarantino, 2014 .

From bed to bench: which attitude towards the laboratory liver tests should health care practitioners strike?

G. Tarantino, 2007, World journal of gastroenterology.

Oleuropein overrides liver damage in steatotic mice

G. Tarantino, F. Amicarelli, C. Balsano, 2020, Journal of Functional Foods.

Pathogenesis of hepatic steatosis: the link between hypercortisolism and non-alcoholic fatty liver disease.

G. Tarantino, C. Finelli, 2013, World journal of gastroenterology.

Nutrition: a promising route for prevention and management of obesity-related nonalcoholic fatty liver disease

G. Tarantino, 2014, Hormone molecular biology and clinical investigation.

Nesfatin-1: role as possible new anti-obesity treatment

G. Tarantino, M. Padula, R. Rossano, 2014, EXCLI journal.

Hepatitis C virus lymphotropism and peculiar immunological phenotype: effects on natural history and antiviral therapy.

G. Tarantino, P. Conca, 2009, World journal of gastroenterology.

Rheumatoid factor after antiviral therapy in patients with HCV chronic hepatitis.

G. Tarantino, A. Riccio, P. Conca, 2008, Clinical and experimental rheumatology.

EC‐MPS permits lower gastrointestinal symptom burden despite higher MPA exposure in patients with severe MMF‐related gastrointestinal side‐effects

M. Sabbatini, S. Federico, A. Pisani, 2009, Fundamental & clinical pharmacology.

Circulating levels of interferon-gamma in course of hepatitis C virus-related arthritis.

G. Tarantino, A. Riccio, P. Sabatini, 2009, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

The use of interferon-alpha in a small cohort of patients with a type of idiopathic pulmonary fibrosis, probably post-cryoglobulinaemia, hepatitis C virus related.

G. Tarantino, M. D. Di Minno, M. Mastrolia, 2005, European journal of gastroenterology & hepatology.

Blood ammonia levels in liver cirrhosis: a clue for the presence of portosystemic collateral veins

G. Tarantino, G. Milan, P. Esposito, 2009, BMC gastroenterology.

What are the implications of the spontaneous spleno-renal shunts in liver cirrhosis?

G. Tarantino, D. Capone, A. Riccio, 2009, BMC gastroenterology.

Could Alcohol Abuse and Dependence on Junk Foods Inducing Obesity and/or Illicit Drug Use Represent Danger to Liver in Young People with Altered Psychological/Relational Spheres or Emotional Problems?

M. Cataldi, G. Tarantino, V. Citro, 2022, International journal of molecular sciences.

Does protracted antiviral therapy impact on HCV-related liver cirrhosis progression?

G. Tarantino, D. Capone, A. Gentile, 2007, World journal of gastroenterology.

Cytokine network during NASH and possible treatment selection

G. Tarantino, G. Borgia, O. Perrella, 2003, Hepatology.

CD4+ T lymphocytes and cryoglobulins in patients coinfected with HIV and hepatitis C virus: forgetting the hidden CD4+ cell subsets.

G. Tarantino, G. Borgia, O. Perrella, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

“Obesity paradox” or “metabolically benign obesity”?

G. Tarantino, C. Finelli, 2013, Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity.

Is spleen circulation impaired in systemic sclerosis and what is the role of liver fibrosis?

G. Tarantino, A. Riccio, G. Gaeta, 2011, World journal of gastroenterology.

Silent non-alcoholic fatty liver disease-a clinical-histological study.

G. Tarantino, A. Perrella, N. Gennarelli, 2004, Journal of hepatology.

Can Serum TGF-BETA 1 Be Used to Evaluate the Response to Antiviral Therapy of Haemophilic Patients with HCV-Related Chronic Hepatitis ?

G. Tarantino, G. Di Minno, A. Coppola, 2008, International journal of immunopathology and pharmacology.

G. Tarantino, Xiaoxi Wang, X. Qi, 2015, Medicine.

Flow cytometry assay of myeloid dendritic cells (mDCs) in peripheral blood during acute hepatitis C: possible pathogenetic mechanisms.

G. Tarantino, O. Perrella, A. Perrella, 2006, World journal of gastroenterology.

Obesity and the Liver: Cell Death, Compensatory Growth, and Repair of Damage

G. Tarantino, 2014 .

Synchronous Onset of Secondary Raynaud's Phenomenon in Monozygotic Twins

G. Tarantino, A. Riccio, M. G. Sangiolo, 2012 .

Non-alcoholic fatty liver disease, obesity and other illnesses.

G. Tarantino, 2008, Clinical and investigative medicine. Medecine clinique et experimentale.

Evalutation of mycophenolic acid systemic exposure by limited sampling strategy in kidney transplant recipients receiving enteric-coated mycophenolate sodium (EC-MPS) and cyclosporine.

M. Sabbatini, S. Federico, G. Tarantino, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire

P. Macchia, M. Napolitano, N. Balato, 2015, Journal of Translational Medicine.

Drug-induced liver injury: is it somehow foreseeable?

G. Tarantino, D. Capone, M. D. Di Minno, 2009, World journal of gastroenterology.

Spleen: A new role for an old player?

A. Colao, G. Tarantino, D. Capone, 2011, World journal of gastroenterology.

Hepatitis C Virus-Related Arthtitis and Rheumatoid Arthritis: Could They Be Different Aspects of the Same Disease?

G. Tarantino, A. Riccio, 2012, International journal of immunopathology and pharmacology.

Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?

G. Tarantino, A. Scalera, 2014, World journal of gastroenterology.

Successful Lamivudine Monotherapy in an Elderly Patient Suffering from HBV-Related Decompensated Cirrhosis Associated with Widespread Leukocytoclastic Vasculitis

G. Tarantino, A. Riccio, P. Conca, 2009, International journal of immunopathology and pharmacology.

Non-alcoholic fatty liver disease, diet and gut microbiota

G. Tarantino, C. Finelli, 2014, EXCLI journal.

Metabolic factors involved in the therapeutic response of patients with hepatitis C virus‐related chronic hepatitis

G. Tarantino, P. Conca, P. Sorrentino, 2006, Journal of gastroenterology and hepatology.

Endocrine changes (beyond diabetes) after bariatric surgery in adult life

F. Orio, A. Colao, G. Tarantino, 2013, Journal of Endocrinological Investigation.

Steatosis, Steatohepatitis and Cancer Immunotherapy: An Intricate Story

M. Cataldi, G. Tarantino, F. Manco, 2021, International journal of molecular sciences.

Inhibition of the mTOR pathway: A possible protective role in coronary artery disease

G. Tarantino, D. Capone, 2013, Annals of medicine.

Drug-induced liver injury due to "natural products" used for weight loss: a case report.

G. Tarantino, D. Capone, M. D. Di Minno, 2009, World journal of gastroenterology.

Gastrointestinal peptides and nonalcoholic fatty liver disease.

G. Tarantino, C. Balsano, 2019, Current opinion in endocrinology, diabetes, and obesity.

Age and Interleukin-15 Levels Are Independently Associated With Intima-Media Thickness in Obesity-Related NAFLD Patients

G. Tarantino, D. Capone, C. Balsano, 2021, Frontiers in Medicine.

Is Assessing the Presence of NASH by Liver Histology or Surrogate Markers Always Advisable?

G. Tarantino, 2013, Hepatitis monthly.

Is There a Link between Basal Metabolic Rate, Spleen Volume and Hepatic Growth Factor Levels in Patients with Obesity-Related NAFLD?

G. Tarantino, D. Capone, C. Balsano, 2019, Journal of clinical medicine.

Hepatic and peripheral T-lymphocyte patterns in patients with chronic hepatitis C infection: what correlation with histological activity?

G. Tarantino, O. Perrella, A. Perrella, 2001, International journal of immunopathology and pharmacology.

Systematic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease.

G. Tarantino, C. Finelli, 2015, Future microbiology.

Could the depression of obese patients suffering from chronic hepatitis C be temporarily improved?

G. Tarantino, D. Capone, A. Gentile, 2008, Journal of viral hepatitis.

Non-alcoholic fatty liver disease, diet and gut microbiota

G. Tarantino, C. Finelli, 2014, EXCLI journal.

Review article: NONALCOHOLIC FATTY LIVER DISEASE, DIET AND GUT MICROBIOTA

G. Tarantino, C. Finelli, S. Lucia, 2014 .

Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance.

A. Colao, G. Tarantino, S. Savastano, 2010, World journal of gastroenterology.

Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease.

A. Colao, G. Tarantino, D. Capone, 2011, Journal of biological regulators and homeostatic agents.

Do Thyroid Abnormalities Detected in Patients Treated for HCV-Related Chronic Hepatitis Persist?

G. Tarantino, G. Gagliardi, P. Conca, 2008, International journal of immunopathology and pharmacology.

Could SCGF-Beta Levels Be Associated with Inflammation Markers and Insulin Resistance in Male Patients Suffering from Obesity-Related NAFLD?

G. Tarantino, D. Capone, C. Balsano, 2020, Diagnostics.

Nonalcoholic Fatty Liver Disease: A Challenge from Mechanisms to Therapy

G. Tarantino, D. Capone, V. Citro, 2019, Journal of clinical medicine.

Exposure to ambient air particulate matter and non-alcoholic fatty liver disease.

G. Tarantino, D. Capone, Domenico Capone, 2013, World journal of gastroenterology.

Beyond Nutrition Is There Any Role for Physical Activity in Nonalcoholic Fatty Liver Disease Therapy

G. Tarantino, C. Finelli, 2014 .

What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?

G. Tarantino, C. Finelli, 2013, World journal of gastroenterology.

Have guidelines addressing physical activity been established in nonalcoholic fatty liver disease?

G. Tarantino, C. Finelli, 2012, World journal of gastroenterology.

UCP1 -3826 AG+GG genotypes, adiponectin, and leptin/adiponectin ratio in severe obesity

G. Tarantino, F. Contaldo, F. Pasanisi, 2009 .

Should nonalcoholic fatty liver disease be regarded as a hepatic illness only?

G. Tarantino, 2007, World journal of gastroenterology.

TNF-α inhibitors and tocilizumab do not influence hepatic steatosis in patients with rheumatoid arthritis

G. Tarantino, G. Valentini, M. D. Minno, 2014 .

Hepatic steatosis in overweight/obese females: new screening method for those at risk.

A. Colao, G. Tarantino, S. Savastano, 2009, World journal of gastroenterology.

Association of NAFLD and Insulin Resistance with Non Metastatic Bladder Cancer Patients: A Cross-Sectional Retrospective Study

M. Creta, G. Tarantino, D. Capone, 2021, Journal of clinical medicine.

Hematocrit Values Predict Carotid Intimal-Media Thickness in Obese Patients With Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study

G. Tarantino, D. Capone, L. Barrea, 2018, Front. Endocrinol..

A Comparative Study of the Triglycerides/HDL Ratio and Pseudocholinesterase Levels in Patients with Bladder Cancer

G. Tarantino, C. Imbimbo, F. Crocetto, 2022, Diagnostics.

Basal metabolic rate in morbidly obese patients with non-alcoholic fatty liver disease.

G. Tarantino, F. Contaldo, F. Pasanisi, 2008, Clinical and investigative medicine. Medecine clinique et experimentale.

Do Transferrin Levels Predict Haemodialysis Adequacy in Patients with End-Stage Renal Disease?

G. Tarantino, D. Capone, C. Balsano, 2019, Nutrients.

Corrigendum to “Circulating Levels of Sirtuin 4, a Potential Marker of Oxidative Metabolism, Related to Coronary Artery Disease in Obese Patients Suffering from NAFLD, with Normal or Slightly Increased Liver Enzymes”

G. Tarantino, D. Capone, S. Savastano, 2018, Oxidative medicine and cellular longevity.

Is serum Interleukin-17 associated with early atherosclerosis in obese patients?

S. Costantini, G. Tarantino, G. Castello, 2014, Journal of Translational Medicine.

Circulating Levels of Sirtuin 4, a Potential Marker of Oxidative Metabolism, Related to Coronary Artery Disease in Obese Patients Suffering from NAFLD, with Normal or Slightly Increased Liver Enzymes

G. Tarantino, D. Capone, S. Savastano, 2014, Oxidative medicine and cellular longevity.

A pharmacokinetic interaction between clarithromycin and sirolimus in kidney transplant recipient.

M. Sabbatini, S. Federico, A. Perfetti, 2007, Current drug metabolism.

Reticulocyte Hemoglobin Content Helps Avoid Iron Overload in Hemodialysis Patients: A Retrospective Observational Study.

M. Cataldi, G. Tarantino, D. Capone, 2017, In vivo.

Abnormally high resistive index of central retinal artery by ultrasound color Doppler in patients with viral chronic liver disease: correlation with worsening liver staging.

G. Tarantino, Paolo Sorrentino, A. Perrella, 2004, Ultrasound in medicine & biology.

Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease.

A. Colao, G. Tarantino, D. Capone, 2011, World journal of gastroenterology.

A Life-Threating Postpartum Atypical Hemolytic-Uremic Syndrome with Multiorgan Involvement

G. Tarantino, L. Sarno, M. Guida, 2022, Journal of clinical medicine.

Adherence to the Mediterranean Diet and Circulating Levels of Sirtuin 4 in Obese Patients: A Novel Association

P. Macchia, G. Muscogiuri, A. Colao, 2017, Oxidative medicine and cellular longevity.

Bisphenol-A plasma levels are related to inflammatory markers, visceral obesity and insulin-resistance: a cross-sectional study on adult male population

S. Cabaro, G. Perruolo, P. Formisano, 2015, Journal of Translational Medicine.

Troponin Levels Relate to CRP Concentrations in Patients With NAFLD on Maintenance Haemodialysis: A Retrospective Study

G. Tarantino, D. Capone, V. Citro, 2020, Advances in Therapy.

Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?

G. Tarantino, C. Finelli, 2013, Hepatology International.

What non-alcoholic fatty liver disease has got to do with obstructive sleep apnoea syndrome and viceversa?

G. Tarantino, V. Citro, C. Finelli, 2014, Journal of gastrointestinal and liver diseases : JGLD.

Sublingual administration improves systemic exposure of tacrolimus in kidney transplant recipients: comparison with oral administration

M. Sabbatini, L. Russo, S. Federico, 2016, European journal of clinical investigation.

Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?

D. Chianese, G. Tarantino, D. Capone, 2008, Journal of Translational Medicine.

Could inflammatory markers help diagnose nonalcoholic steatohepatitis?

G. Tarantino, F. Pasanisi, M. Mastrolia, 2009, European journal of gastroenterology & hepatology.

Insulin resistance and hepatitis C.

G. Tarantino, 2005, Gastroenterology.

Is fatty liver always benign and should not consequently be treated?

C. Fierbinţeanu-Braticevici, G. Tarantino, L. Negreanu, 2013, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

Interferon-alpha 2 but not Interferon-gamma serum levels are associated with intramuscular fat in obese patients with nonalcoholic fatty liver disease

S. Costantini, G. Tarantino, D. Capone, 2019, Journal of Translational Medicine.

Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non‐alcoholic steatohepatitis

G. Tarantino, G. Di Minno, A. Coppola, 2007, European journal of clinical investigation.

Effects of Ambient Air Pollution on Birth Outcomes: An Overview

G. Tarantino, D. Capone, G. Polichetti, 2013 .

Effects of Ambient Air Pollution on Birth Outcomes: An Overview

G. Tarantino, D. Capone, G. Polichetti, 2013 .

Gut microbiome, obesity-related comorbidities, and low-grade chronic inflammation.

G. Tarantino, 2014, The Journal of clinical endocrinology and metabolism.

Transforming growth factor beta-1 and interferon-alpha in the AIDS dementia complex (ADC): possible relationship with cerebral viral load?

G. Tarantino, O. Perrella, A. Perrella, 2001, European cytokine network.

Analytical and pharmacological aspects of therapeutic drug monitoring of mTOR inhibitors.

G. Tarantino, D. Capone, G. Polichetti, 2011, Current drug metabolism.

Mental status impairment in patients with West Haven grade zero hepatic encephalopathy: the role of HCV infection

G. Tarantino, G. Milan, A. Gennari, 2007, Journal of Gastroenterology.

A prospective study of acute drug‐induced liver injury in patients suffering from non‐alcoholic fatty liver disease

G. Tarantino, D. Capone, G. Polichetti, 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire

P. Macchia, M. Napolitano, N. Balato, 2015, Journal of Translational Medicine.

CD8+/CD38+: immune activity and clinical significance in HCV patients with and without interferon therapy.

G. Tarantino, A. Perrella, P. Conca, 2000, European review for medical and pharmacological sciences.

Does a lower insulin resistance affect antiviral therapy response in patients suffering from HCV related chronic hepatitis?

G. Tarantino, M. Mastrolia, P. Conca, 2006, Gut.

Urinary Excretion of 5-Hydroxy-3-Indoleacetic Acid in Dystimic/Depressed, Adult Obese Women: What Correlations to Hepatic Steatosis?

A. Colao, G. Tarantino, D. Capone, 2011, International journal of immunopathology and pharmacology.

The contribution of omental adipose tissue to adipokine concentrations in patients with the metabolic syndrome.

G. Tarantino, F. Contaldo, F. Pasanisi, 2007, Clinical and investigative medicine. Medecine clinique et experimentale.

Exaggerated Immune Reactions Predict the Outcome of Interferon Therapy in Patients with Chronic Hepatitis C

G. Tarantino, P. Conca, A. Arena, 2007, International journal of immunopathology and pharmacology.

Does Spleen Volume Play a Role in Patients with HCV-Related Chronic Hepatitis?

D. Chianese, G. Tarantino, D. Capone, 2009, International journal of immunopathology and pharmacology.

G. Tarantino, A. Riccio, L. Postiglione, 2012, International journal of immunopathology and pharmacology.

Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis C (and Congenital Bleeding Disorders): Where Do We Stand?

G. Tarantino, G. Di Minno, A. Coppola, 2013, Seminars in Thrombosis & Hemostasis.

Analysis of extracellular superoxide dismutase in fibroblasts from patients with systemic sclerosis.

M. R. Ruocco, A. Arcucci, G. Tarantino, 2011, Journal of biological regulators and homeostatic agents.

Should octreotide be used cautiously in liver cirrhosis with concomitant congestive heart failure correlated to coronary artery disease?

G. Tarantino, A. Perrella, P. Conca, 2003, Digestive diseases and sciences.

Sarcopenia, a condition shared by various diseases: can we alleviate or delay the progression?

G. Tarantino, C. Balsano, V. Citro, 2023, Internal and Emergency Medicine.

What has the optimistic bias got to do with the need to differentiate fatty liver from nonalcoholic steatohepatitis?

G. Tarantino, 2011, Journal of gastrointestinal and liver diseases : JGLD.

Bisphenol-A plasma levels are related to inflammatory markers, visceral obesity and insulin-resistance: a cross-sectional study on adult male population

P. Formisano, F. Beguinot, G. Tarantino, 2015, Journal of Translational Medicine.

Suggestive hypothesis on a case report: Patient presenting with cyclical ovarian cysts coupled to increased cholestatic enzymes

G. Tarantino, S. Savastano, A. Coppola, 2018, The journal of obstetrics and gynaecology research.

Abnormally high prevalence of major components of the metabolic syndrome in subjects with early-onset idiopathic venous thromboembolism.

G. Tarantino, G. Di Minno, G. Minno, 2011, Thrombosis research.

Pharmacomicrobiomics of Classical Immunosuppressant Drugs: A Systematic Review

B. Guida, Mariastella Di Lauro, M. Cataldi, 2023, Biomedicines.

LETTER: Should Octreotide Be Used Cautiously in Liver Cirrhosis with Concomitant Congestive Heart Failure Correlated to Coronary Artery Disease?

G. Tarantino, A. Perrella, P. Conca, 2003, Digestive Diseases and Sciences.

UCP1 -3826 AG+GG genotypes, adiponectin, and leptin/adiponectin ratio in severe obesity.

G. Tarantino, F. Contaldo, F. Pasanisi, 2009, Journal of endocrinological investigation.

Could inflammatory markers help diagnose nonalcoholic steatohepatitis?

G. Tarantino, F. Pasanisi, M. Mastrolia, 2009, European journal of gastroenterology & hepatology.

Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease.

G. Tarantino, A. Di Minno, P. Ambrosino, 2012, World journal of gastroenterology.

Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?

D. Chianese, G. Tarantino, D. Capone, 2008, Journal of Translational Medicine.

Comparison of the everolimus concentrations measured in whole blood with everolimus QMS or sirolimus CMIA

B. Guida, M. Cataldi, G. Tarantino, 2018, Scandinavian journal of clinical and laboratory investigation.

What non-alcoholic fatty liver disease has got to do with obstructive sleep apnoea syndrome and viceversa?

G. Tarantino, V. Citro, C. Finelli, 2014, Journal of gastrointestinal and liver diseases : JGLD.